Astronaut Vision Issues in a Ground Analog Population: Polycystic Ovary Syndrome
NCT02896452 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2025-05-22
Summary
The investigators have documented a genetic predisposition for some astronauts to develop ophthalmologic issues (e.g., choroidal folds, cotton wool spots, optic disc edema). Women with polycystic ovary syndrome (PCOS) have several characteristics similar to those described in astronauts, including: higher homocysteine concentrations, increased incidence of intracranial hypertension, increased retinal nerve fiber layer thickness, increased incidence of white matter hyperintensities on MRI, increased androgen concentrations (or androgen responses to space flight), and indices of altered carbohydrate metabolism. Women with PCOS have not been evaluated in detail regarding the occurrence of other anomalies observed in astronauts including choroidal folds, optic disc edema and cotton wool spots as well as changes in cycloplegic refraction, and optic nerve sheath diameter. While researchers have evaluated one-carbon metabolism pathway polymorphisms re: PCOS, and initial studies show an association with certain one-carbon polymorphisms, none have looked at the complete set of SNPs proposed here. This study will evaluate women with PCOS and/or idiopathic intracranial hypertension (IIH) to assess one-carbon biochemistry and genetics and their possible correlation with ophthalmologic findings. The investigators aim to clarify the relationship of one carbon metabolism and ophthalmic findings in astronauts and patients with PCOS and/or IIH.
Conditions
- Polycystic Ovarian Syndrome
- Idiopathic Intracranial Hypertension
Sponsors & Collaborators
-
University of Texas
collaborator OTHER - collaborator OTHER
-
University of Florida
collaborator OTHER -
University of North Carolina
collaborator OTHER -
Coastal Eye Associates
collaborator UNKNOWN -
National Aeronautics and Space Administration
lead UNKNOWN
Principal Investigators
-
Scott M Smith, PhD · National Aeronautics and Space Administration (NASA)
-
Alice Y Chang, MD · Mayo Clinic
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-10-01
- Primary Completion
- 2020-03-31
- Completion
- 2026-09-30
Countries
- United States
Study Locations
More Related Trials
-
The Secretion of Incretin Hormones in Patients With Polycystic Ovary Syndrome
NCT02126592 ·Status: UNKNOWN
-
MicroRNA as Biomarkers for Development of Metabolic Syndrome in Women With Polycystic Ovary Syndrome
NCT03142633 ·Status: COMPLETED
-
Ultrasonographic Evaluation of Anovulatory Disorders in Lean and Overweight Women
NCT03306849 ·Status: COMPLETED
-
Brain Metabolism in Polycystic Ovary Syndrome
NCT02409914 ·Status: COMPLETED
-
Ovarian Morphology and Theca Cell Androgen Production in Women With Polycystic Ovary Syndrome (PCOS)
NCT02145247 ·Status: COMPLETED ·Phase: NA
-
Characterization of a Prospective Cohort of Women With PCOS
NCT02010814 ·Status: RECRUITING
-
Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
NCT03652987 ·Status: SUSPENDED
-
Dry Eye in Women With Turner Syndrome and Women With Premature Ovarian Failure
NCT00471731 ·Status: COMPLETED
-
Gut Microbiome in Patients With Polycystic Ovary Syndrome
NCT02078505 ·Status: UNKNOWN ·Phase: NA
-
Ovarian Morphology in Girls
NCT04424576 ·Status: RECRUITING
-
Etiological Factors of Obesity-Associated Hyperandrogenemia in Peripubertal Girls
NCT00928759 ·Status: UNKNOWN
-
Environmental Factors in the Development of Polycystic Ovary Syndrome
NCT00341731 ·Status: COMPLETED
-
Research Study for Children With a Mother or Sister With Polycystic Ovary Syndrome
NCT00559390 ·Status: COMPLETED
-
Potential Impact of Polycystic Ovarian Syndrome on Protein Modifications and Accumulation
NCT02105428 ·Status: COMPLETED ·Phase: NA
-
PCOS Twin Study - Environmental Factors in the Development of Polycystic Ovary Syndrome, Phase 2
NCT00444288 ·Status: COMPLETED
-
Ovarian Ultrasonography for the Clinical Evaluation of Polycystic Ovary Syndrome
NCT03547453 ·Status: COMPLETED
-
Sebum Excretion in Neonates of Women With Polycystic Ovary Syndrome (PCOS)
NCT02654548 ·Status: COMPLETED ·Phase: NA
-
Heritability of Polycystic Ovary Syndrome: Role of Antimullerian Hormone, Steroids and Leptin
NCT03483792 ·Status: COMPLETED
-
Blood Vessel Function in Adolescents and Women With Polycystic Ovary Syndrome
NCT01615562 ·Status: TERMINATED
-
Comparison of Lifestyle Markers Between Women With and Without Polycystic Ovary Syndrome
NCT01859663 ·Status: COMPLETED
-
Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS
NCT03252223 ·Status: COMPLETED ·Phase: PHASE4
-
Intestinal Microbiota Survey of Polycystic Ovary Syndrome
NCT02937090 ·Status: COMPLETED
-
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
NCT03905603 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Primary Ovarian Insufficiency, Polycystic Ovary Syndrome & the CardiOvascular Risk Profile
NCT02616510 ·Status: COMPLETED
-
Effect of Hyperandrogenism on IVF Outcomes in PCOS Patients
NCT05555680 ·Status: TERMINATED